Back
Gilead Sciences Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
32
GILD
Gilead Sciences
Last Price:
67.61
Seasonality Move:
6.01%
Sell
37
BMY
Bristol-Myers Squibb
Last Price:
44.61
Seasonality Move:
-0.39%
Sell
32
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $67.65. The Score for GILD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- GILD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.71. The Score for BMY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $67.65
The current trend is relatively stagnant and GILD is experiencing slight selling pressure.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 53.33 | Buy |
Chaikin Money Flow: | -374094 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.24 - 67.56) | Buy |
Bollinger Bands (100): | (67.9 - 80.2) | Sell |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.42 | Sell |
Relative Strength Index (14 RSI): | 36.49 | Sell |
Chaikin Money Flow: | -9115232 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.04 - 48.56) | Sell |
Bollinger Bands (100): | (47.2 - 52.56) | Sell |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.8 | Buy |
20-day SMA: | 66 | Buy |
50-day SMA: | 69.61 | Sell |
200-day SMA: | 75.63 | Sell |
8-day EMA: | 66.27 | Buy |
20-day EMA: | 66.58 | Buy |
50-day EMA: | 69.05 | Sell |
200-day EMA: | 74.31 | Sell |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.38 | Buy |
20-day SMA: | 45.66 | Sell |
50-day SMA: | 49.41 | Sell |
200-day SMA: | 53 | Sell |
8-day EMA: | 44.68 | Buy |
20-day EMA: | 45.76 | Sell |
50-day EMA: | 47.96 | Sell |
200-day EMA: | 53.26 | Sell |
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.00 per share, and an increase next year of $3.41 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.22 per share, a decrease this year of $6.86 per share, and an increase next year of $6.41 per share.
Gilead Sciences Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |